BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/24/2017 2:45:21 AM | Browse: 1566 | Download: 3174
Publication Name World Journal of Clinical Infectious Diseases
Manuscript ID 30282
Country India
ISSN 2220-3176 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Basic Study
Article Title Antioxidant enzyme profile of two clinical isolates of Entamoeba histolytica varying in sensitivity to antiamoebic drugs
Manuscript Source Invited Manuscript
All Author List Lakshmi Rani Iyer, Neha Banyal, Shailendra Naik and Jaishree Paul
Funding Agency and Grant Number
Funding Agency Grant Number
Department of Science and Technology, New Delhi, Government of India to Iyer LR WOS-A/LS-98/2007
“Programme support on molecular parasitology”, Department of Biotechnology, New Delhi, India BT/01/CEIB/11/V/08 (to Paul J)
Corresponding Author Dr. Jaishree Paul, School of Life Sciences, Jawaharlal Nehru University, New Mehrauli Road, New Delhi 110067, India. jpaul33@hotmail.com
Key Words Metronidazole; Entamoeba histolytica; Amoebiasis; Thioredoxin reductase; Isolates; Tolerance; Auranofin; Minimum inhibitory concentrations
Core Tip Due to overuse of the mainstay drug against amoebiasis in an endemic country like India, there are concerns regarding the development of resistance towards metronidazole by the parasite. When Entamoeba histolytica (E. histolytica) from stool samples of diarrheal patients were cultivated in xenic medium, two clinical isolates of E. histolytica showed differential tolerance to the commonly used drug metronidazole. A new drug Auranofin was found to be effective on the isolate with higher tolerance to metronidazole. This was shown by inhibition of the antioxidant enzyme thioredoxin reductase as monitored by mRNA expression of TrxR gene and its enzyme activy.
Publish Date 2017-05-24 02:45
Citation Iyer LR, Banyal N, Naik S, Paul J. Antioxidant enzyme profile of two clinical isolates of Entamoeba histolytica varying in sensitivity to antiamoebic drugs. World J Clin Infect Dis 2017; 7(2): 21-31
URL http://www.wjgnet.com/2220-3176/full/v7/i2/21.htm
DOI http://dx.doi.org/10.5495/wjcid.v7.i2.21
Full Article (PDF) WJCID-7-21.pdf
Full Article (Word) WJCID-7-21.doc